Amneal Pharmaceuticals Inc (AMRX.N)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- UPDATE 2-U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
- U.S. mergers help bank fees spike to record highs
- US mergers help bank fees spike to record highs
- BRIEF-Amneal Announces FDA Approval And Launch Of Generic Welchol® (Colesevelam Hcl) Tablets, 625 Mg
- BRIEF-Fosun International Reports 6.8 Pct Passive Stake In Amneal Pharma